Cargando…

Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients

BACKGROUND: In schizophrenia, sex specific dimorphisms related to age of onset, course of illness and response to antipsychotic treatment may be mirrored by sex-related differences in the underlying molecular pathways. METHODOLOGY/PRINCIPAL FINDINGS: Here, we have carried out multiplex immunoassay p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramsey, Jordan M., Schwarz, Emanuel, Guest, Paul C., van Beveren, Nico J. M., Leweke, F. Markus, Rothermundt, Matthias, Bogerts, Bernhard, Steiner, Johann, Bahn, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823995/ https://www.ncbi.nlm.nih.gov/pubmed/24244349 http://dx.doi.org/10.1371/journal.pone.0078729

Ejemplares similares

Molecular Sex Differences in Human Serum
por: Ramsey, Jordan M., et al.
Publicado: (2012)

Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia
por: Schwarz, Emanuel, et al.
Publicado: (2010)

Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
por: Schwarz, E, et al.
Publicado: (2012)

Clinical bioinformatics for complex disorders: a schizophrenia case study
por: Schwarz, Emanuel, et al.
Publicado: (2009)

Multimodel inference for biomarker development: an application to schizophrenia
por: Cooper, Jason D., et al.
Publicado: (2019)

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment
por: Steiner, Johann, et al.
Publicado: (2020)

S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance
por: Steiner, Johann, et al.
Publicado: (2010)

Comparison of Peripheral and Central Schizophrenia Biomarker Profiles
por: Harris, Laura W., et al.
Publicado: (2012)

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
por: Chan, M K, et al.
Publicado: (2015)

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia
por: van Beveren, N J M, et al.
Publicado: (2014)

Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
por: Guest, Paul C, et al.
Publicado: (2013)

Reduced anterior insular cortex volume in male heroin addicts: a postmortem study
por: Müller, Ulf J., et al.
Publicado: (2023)

Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases
por: Schwarz, Emanuel, et al.
Publicado: (2012)

Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia
por: Krzyżanowska, Marta, et al.
Publicado: (2014)

Serum proteomic profiling of major depressive disorder
por: Bot, M, et al.
Publicado: (2015)

Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
por: Ramsey, Jordan M., et al.
Publicado: (2016)

Profiling of CSF: Author's Reply
por: Bahn, Sabine, et al.
Publicado: (2006)

Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits
por: Falkai, Peter, et al.
Publicado: (2016)

The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
por: Brisch, Ralf, et al.
Publicado: (2014)

Corrigendum: The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
por: Brisch, Ralf, et al.
Publicado: (2014)

Cardiac Responses during Picture Viewing in Young Male Patients with Schizophrenia
por: Hempel, Roelie J., et al.
Publicado: (2012)

Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei
por: Brisch, Ralf, et al.
Publicado: (2015)

Inflammation and viral infection as disease modifiers in schizophrenia
por: Klein, Hans C., et al.
Publicado: (2023)

Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots
por: Cooper, Jason D., et al.
Publicado: (2017)

A Visual Metaphor Describing Neural Dynamics in Schizophrenia
por: van Beveren, Nico J. M., et al.
Publicado: (2008)

Associations between SNPs and immune-related circulating proteins in schizophrenia
por: Chan, Man K., et al.
Publicado: (2017)

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia
por: Holmes, Elaine, et al.
Publicado: (2006)

Male increase in brain gene expression variability is linked to genetic risk for schizophrenia
por: Chen, Junfang, et al.
Publicado: (2018)

Changes in leukocytes and CRP in different stages of major depression
por: Singh, Deepti, et al.
Publicado: (2022)

Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder
por: Bernstein, Hans-Gert, et al.
Publicado: (2015)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

Evidence for a wide extra-astrocytic distribution of S100B in human brain
por: Steiner, Johann, et al.
Publicado: (2007)

The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
por: Lago, Santiago G., et al.
Publicado: (2022)

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders
por: Wesseling, Hendrik, et al.
Publicado: (2014)

Distinct molecular etiologies of male and female hepatocellular carcinoma
por: Natri, Heini M., et al.
Publicado: (2019)

IRSp53 Deletion in Glutamatergic and GABAergic Neurons and in Male and Female Mice Leads to Distinct Electrophysiological and Behavioral Phenotypes
por: Kim, Yangsik, et al.
Publicado: (2020)

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)
por: Ramsey, Jordan M., et al.
Publicado: (2016)

Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response
por: Martins-de-Souza, Daniel, et al.
Publicado: (2015)

Corrigendum: IRSp53 Deletion in Glutamatergic and GABAergic Neurons and in Male and Female Mice Leads to Distinct Electrophysiological and Behavioral Phenotypes
por: Kim, Yangsik, et al.
Publicado: (2021)

Distinct Genetic Architectures for Male and Female Inflorescence Traits of Maize
por: Brown, Patrick J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tq5q6ne4dkqft8mehp071hfmnm